Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:2370436rdf:typepubmed:Citationlld:pubmed
pubmed-article:2370436lifeskim:mentionsumls-concept:C0302592lld:lifeskim
pubmed-article:2370436lifeskim:mentionsumls-concept:C0008838lld:lifeskim
pubmed-article:2370436lifeskim:mentionsumls-concept:C0001561lld:lifeskim
pubmed-article:2370436pubmed:issue4lld:pubmed
pubmed-article:2370436pubmed:dateCreated1990-8-23lld:pubmed
pubmed-article:2370436pubmed:abstractTextAn 84-year-old woman was seen on June 19, 1989 with the chief complaint of excessive abnormal genital bleeding of 10 days' duration. The patient was diagnosed as FIGO stage IV b (positive metastasis to lung and Virchow's nodes) and was urgently admitted because of massive bleeding, which was well controlled by whole pelvic irradiation (Lineac 3,000 rad). However, subsequent 3 courses of systemic combination chemotherapy including cisplatin delivered progressing disease (PD) with the evidence of exacerbation of primary and metastatic lesions. In such an intelligible case, authors applied 5 mg of CDDP for 13 consecutive days directly into the vaginal wall and made a pharmaco-dynamic kinetic study by measuring the blood and tissue Pt concentration. Cyto- and pathological analysis of tissue specimen revealed that this topical used of low-dose consecutive CDDP was effective for local tumor control even after failure of systemic chemotherapy.lld:pubmed
pubmed-article:2370436pubmed:languagejpnlld:pubmed
pubmed-article:2370436pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2370436pubmed:citationSubsetIMlld:pubmed
pubmed-article:2370436pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2370436pubmed:statusMEDLINElld:pubmed
pubmed-article:2370436pubmed:monthAprlld:pubmed
pubmed-article:2370436pubmed:issn0021-4671lld:pubmed
pubmed-article:2370436pubmed:authorpubmed-author:ShimizuYYlld:pubmed
pubmed-article:2370436pubmed:authorpubmed-author:NakayamaKKlld:pubmed
pubmed-article:2370436pubmed:authorpubmed-author:MasubuchiKKlld:pubmed
pubmed-article:2370436pubmed:authorpubmed-author:HasumiKKlld:pubmed
pubmed-article:2370436pubmed:issnTypePrintlld:pubmed
pubmed-article:2370436pubmed:day20lld:pubmed
pubmed-article:2370436pubmed:volume25lld:pubmed
pubmed-article:2370436pubmed:ownerNLMlld:pubmed
pubmed-article:2370436pubmed:authorsCompleteYlld:pubmed
pubmed-article:2370436pubmed:pagination826-9lld:pubmed
pubmed-article:2370436pubmed:dateRevised2011-7-28lld:pubmed
pubmed-article:2370436pubmed:meshHeadingpubmed-meshheading:2370436-...lld:pubmed
pubmed-article:2370436pubmed:meshHeadingpubmed-meshheading:2370436-...lld:pubmed
pubmed-article:2370436pubmed:meshHeadingpubmed-meshheading:2370436-...lld:pubmed
pubmed-article:2370436pubmed:meshHeadingpubmed-meshheading:2370436-...lld:pubmed
pubmed-article:2370436pubmed:meshHeadingpubmed-meshheading:2370436-...lld:pubmed
pubmed-article:2370436pubmed:meshHeadingpubmed-meshheading:2370436-...lld:pubmed
pubmed-article:2370436pubmed:meshHeadingpubmed-meshheading:2370436-...lld:pubmed
pubmed-article:2370436pubmed:meshHeadingpubmed-meshheading:2370436-...lld:pubmed
pubmed-article:2370436pubmed:year1990lld:pubmed
pubmed-article:2370436pubmed:articleTitle[Intravaginal administration of CDDP in cervical cancer].lld:pubmed
pubmed-article:2370436pubmed:affiliationDepartment of Gynecology, Cancer Institute Hospital.lld:pubmed
pubmed-article:2370436pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:2370436pubmed:publicationTypeEnglish Abstractlld:pubmed